Confronting the barriers to develop novel vaccines against brucellosis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Confronting the barriers to develop novel vaccines against brucellosis
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 10, Issue 9, Pages 1291-1305
Publisher
Informa UK Limited
Online
2011-09-16
DOI
10.1586/erv.11.110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice
- (2011) Karina A. Pasquevich et al. PLoS One
- DNA vaccines for targeting bacterial infections
- (2010) Mariana Ingolotti et al. Expert Review of Vaccines
- Immunization of mice with recombinantS-adenosyl-l-homocysteine hydrolase protein confers protection againstBrucella melitensisinfection
- (2010) Yanling Yang et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- The Brucella abortus Phosphoglycerate Kinase Mutant Is Highly Attenuated and Induces Protection Superior to That of Vaccine Strain 19 in Immunocompromised and Immunocompetent Mice
- (2010) C. G. M. C. Trant et al. INFECTION AND IMMUNITY
- The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis
- (2010) K. A. Pasquevich et al. JOURNAL OF IMMUNOLOGY
- An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response
- (2010) Xi-Dan Hu et al. VACCINE
- Immunopotentiation of live brucellosis vaccine by adjuvants
- (2010) Alexander A. Denisov et al. VACCINE
- Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice
- (2010) Thaís Lourdes Santos Lacerda et al. VACCINE
- BrucellaTIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP
- (2009) Girish K. Radhakrishnan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Subversion of Innate Immune Responses by Brucella through the Targeted Degradation of the TLR Signaling Adapter, MAL
- (2009) D. Sengupta et al. JOURNAL OF IMMUNOLOGY
- Brucella abortus induces Irgm3 and Irga6 expression via type-I IFN by a MyD88-dependent pathway, without the requirement of TLR2, TLR4, TLR5 and TLR9
- (2009) Nicolas Lapaque et al. MICROBIAL PATHOGENESIS
- The Differential Interaction of Brucella and Ochrobactrum with Innate Immunity Reveals Traits Related to the Evolution of Stealthy Pathogens
- (2009) Elías Barquero-Calvo et al. PLoS One
- Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep
- (2009) María B. Barrio et al. VACCINE
- Pathogenesis of bovine brucellosis
- (2009) Alcina V. Carvalho Neta et al. VETERINARY JOURNAL
- Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides
- (2009) Purushottam Kaushik et al. VETERINARY RESEARCH COMMUNICATIONS
- Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection
- (2008) K. A. Pasquevich et al. INFECTION AND IMMUNITY
- The Brucella abortus S19 vjbR Live Vaccine Candidate Is Safer than S19 and Confers Protection against Wild-Type Challenge in BALB/c Mice When Delivered in a Sustained-Release Vehicle
- (2008) A. M. Arenas-Gamboa et al. INFECTION AND IMMUNITY
- Escheriosomes entrapped DNA vaccine co-expressing Cu–Zn superoxide dismutase and IL-18 confers protection against Brucella abortus
- (2008) H SINGHA et al. MICROBES AND INFECTION
- Evidence of Brucella abortus OPS dictating uptake and restricting NF-κB activation in murine macrophages
- (2008) Jianwu Pei et al. MICROBES AND INFECTION
- Brucella: a Mr “Hide” converted into Dr Jekyll
- (2008) Jean-Pierre Gorvel MICROBES AND INFECTION
- Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain–containing proteins
- (2008) Christine Cirl et al. NATURE MEDICINE
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
- Brucellosis Vaccines: Assessment of Brucella melitensis Lipopolysaccharide Rough Mutants Defective in Core and O-Polysaccharide Synthesis and Export
- (2008) David González et al. PLoS One
- Brucella Control of Dendritic Cell Maturation Is Dependent on the TIR-Containing Protein Btp1
- (2008) Suzana P. Salcedo et al. PLoS Pathogens
- A Study on the Use of Male Animal Models for Developing a Live Vaccine for Brucellosis
- (2008) M. J. Izadjoo et al. Transboundary and Emerging Diseases
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
- Challenges in mucosal vaccination of cattle
- (2008) P.E. Shewen et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2
- (2008) M.A. Fiorentino et al. VETERINARY MICROBIOLOGY
- Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu–Zn superoxide dismutase (SOD) gene in cattle
- (2007) Darwin Sáez et al. VETERINARY MICROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started